2025-05-01 2026-04-30 2026-04-30 true 14820770 Millkae Limited 87200Residential care activities for learning difficulties, mental health and substance abuse iso4217:GBP xbrli:pure 148207702025-05-01 148207702026-04-30 148207702025-05-01 2026-04-30 14820770bus:SmallEntities2025-05-01 2026-04-30 14820770bus:AuditExempt-NoAccountantsReport2025-05-01 2026-04-30 14820770bus:FullAccounts2025-05-01 2026-04-30 14820770core:WithinOneYear2026-04-30 14820770core:AfterOneYear2026-04-30 14820770core:WithinOneYear2025-05-01 2026-04-30 14820770core:AfterOneYear2025-05-01 2026-04-30 14820770core:CurrentFinancialInstruments2026-04-30 14820770core:Non-currentFinancialInstruments2026-04-30 14820770core:CurrentFinancialInstruments2025-05-01 2026-04-30 14820770core:Non-currentFinancialInstruments2025-05-01 2026-04-30 14820770core:LandBuildings2025-05-01 2026-04-30 14820770core:FurnitureFittings2025-05-01 2026-04-30 14820770core:OfficeEquipment2025-05-01 2026-04-30 14820770core:Vehicles2025-05-01 2026-04-30 14820770core:PlantMachinery2025-05-01 2026-04-30 14820770core:OtherPropertyPlantEquipment2025-05-01 2026-04-30 14820770core:LandBuildings2026-04-30 14820770core:PlantMachinery2026-04-30 14820770core:Vehicles2026-04-30 14820770core:FurnitureFittings2026-04-30 14820770core:OfficeEquipment2026-04-30 14820770core:OtherPropertyPlantEquipment2026-04-30 14820770core:Right-of-useAssets2025-05-01 2026-04-30 14820770core:Right-of-useAssets2026-04-30 14820770core:Goodwill2025-05-01 2026-04-30 14820770core:PatentsTrademarksLicencesConcessionsSimilar2025-05-01 2026-04-30 14820770core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-05-01 2026-04-30 14820770core:OtherResidualIntangibleAssets2025-05-01 2026-04-30 14820770core:Goodwill2026-04-30 14820770core:DevelopmentCostsCapitalisedDevelopmentExpenditure2026-04-30 14820770core:PatentsTrademarksLicencesConcessionsSimilar2026-04-30 14820770core:OtherResidualIntangibleAssets2026-04-30 14820770dpl:CostSales2025-05-01 2026-04-30 14820770dpl:AdministrativeExpenses2025-05-01 2026-04-30 14820770dpl:DistributionCosts2025-05-01 2026-04-3014820770core:ShareCapital2026-04-30 14820770core:SharePremium2026-04-30 14820770core:RevaluationReserve2026-04-30 14820770core:OtherReservesSubtotal2026-04-30 14820770core:ShareCapitalPreferenceShares2026-04-30 14820770core:CapitalRedemptionReserve2026-04-30 14820770core:OtherCapitalReserve2026-04-30 14820770core:RetainedEarningsAccumulatedLosses2026-04-3014820770core:ShareCapital2025-05-01 2026-04-30 14820770core:SharePremium2025-05-01 2026-04-30 14820770core:RevaluationReserve2025-05-01 2026-04-30 14820770core:OtherReservesSubtotal2025-05-01 2026-04-30 14820770core:RetainedEarningsAccumulatedLosses2025-05-01 2026-04-301482077012025-05-01 2026-04-30 1482077022025-05-01 2026-04-3014820770core:ShareCapital12025-05-01 2026-04-30 14820770core:ShareCapital22025-05-01 2026-04-3014820770core:SharePremium12025-05-01 2026-04-30 14820770core:SharePremium22025-05-01 2026-04-3014820770core:RevaluationReserve12025-05-01 2026-04-30 14820770core:RevaluationReserve22025-05-01 2026-04-3014820770core:RetainedEarningsAccumulatedLosses12025-05-01 2026-04-30 14820770core:RetainedEarningsAccumulatedLosses22025-05-01 2026-04-301482077012025-05-01 2026-04-3014820770core:Non-currentFinancialInstrumentscore:CostValuation2025-05-01 14820770core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-04-30 14820770core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-04-30 14820770core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-04-30 14820770core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2026-04-30 14820770core:Non-currentFinancialInstrumentscore:CostValuation2026-04-3014820770core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-05-01 14820770core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-04-30 14820770core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-04-30 14820770core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-04-30 14820770core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2026-04-30 14820770core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-04-30 14820770core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2026-04-3014820770core:Non-currentFinancialInstruments2026-04-30 14820770core:Non-currentFinancialInstruments2025-04-30148207702024-05-01 148207702025-04-30 148207702024-05-01 2025-04-30 14820770core:WithinOneYear2025-04-30 14820770core:AfterOneYear2025-04-30 14820770core:CurrentFinancialInstruments2025-04-30 14820770core:Non-currentFinancialInstruments2025-04-30 14820770core:LandBuildings2025-04-30 14820770core:PlantMachinery2025-04-30 14820770core:Vehicles2025-04-30 14820770core:FurnitureFittings2025-04-30 14820770core:OfficeEquipment2025-04-30 14820770core:OtherPropertyPlantEquipment2025-04-30 14820770core:Right-of-useAssets2025-04-30 14820770core:Goodwill2025-04-30 14820770core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-04-30 14820770core:PatentsTrademarksLicencesConcessionsSimilar2025-04-30 14820770core:OtherResidualIntangibleAssets2025-04-30 14820770dpl:AdministrativeExpenses2024-05-01 2025-04-3014820770core:ShareCapital2025-04-30 14820770core:SharePremium2025-04-30 14820770core:RevaluationReserve2025-04-30 14820770core:OtherReservesSubtotal2025-04-30 14820770core:ShareCapitalPreferenceShares2025-04-30 14820770core:CapitalRedemptionReserve2025-04-30 14820770core:OtherCapitalReserve2025-04-30 14820770core:RetainedEarningsAccumulatedLosses2025-04-3014820770core:RetainedEarningsAccumulatedLosses2024-05-01 14820770core:ShareCapital2024-05-01 14820770core:SharePremium2024-05-01 14820770core:RevaluationReserve2024-05-01 14820770core:ShareCapital2024-05-01 2025-04-30 14820770core:SharePremium2024-05-01 2025-04-30 14820770core:RevaluationReserve2024-05-01 2025-04-30 14820770core:OtherReservesSubtotal2024-05-01 2025-04-30 14820770core:RetainedEarningsAccumulatedLosses2024-05-01 2025-04-301482077012024-05-01 2025-04-30 1482077022024-05-01 2025-04-3014820770core:ShareCapital12024-05-01 2025-04-30 14820770core:ShareCapital22024-05-01 2025-04-3014820770core:SharePremium12024-05-01 2025-04-30 14820770core:SharePremium22024-05-01 2025-04-3014820770core:RevaluationReserve12024-05-01 2025-04-30 14820770core:RevaluationReserve22024-05-01 2025-04-3014820770core:RetainedEarningsAccumulatedLosses12024-05-01 2025-04-30 14820770core:RetainedEarningsAccumulatedLosses22024-05-01 2025-04-3014820770bus:Director12025-05-01 2026-04-3014820770bus:PrivateLimitedCompanyLtd2025-05-01 2026-04-30
Millkae Limited
Dormant Financial Statements
for the year ended 30 April 2026
Company registration number 14820770
(England and Wales)

Company Information

For the year ended 30 April 2026
Director Ayisi, Millicent Adzoa

Registered office Alleyn House 23-27 Carlton Crescent
Flat 13 Alleyn House
Southampton
SO15 2EU

Registered number 14820770

Accountant 2020 ACCOUNTANCY
Bourne Space
Bourne House
23 Hinton Road
Bournemouth
Bournemouth
BH1 2EF

Statement of Financial Position

As at 30 April 2026
Notes
2026
2025
£
£
£
£
Current assets
Debtors
4
1
1
1
1
Net current assets (liabilities)
1
1
Total assets less current liabilities
1
1
Net assets (liabilities)
1
1
Capital and reserves
Called up share capital
1
1
Total equity
1
1

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 15 July 2026 and are signed on its behalf by:

Ayisi, Millicent Adzoa
Ayisi, Millicent Adzoa
Director

Company registration number 14820770

Notes to the Financial Statements

For the year ended 30 April 2026

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

3. Employees

The average number of employees during the year was 0 (2025: 0).

4. Debtors

2026
2025
£
£
Directors loan accounts
1
1
Total due within one year
1
1
Total due after one year
-
-
Total
1
1